Skip to content

Public FDA record

Z-0421-2024: ICM LNQ22 LINQ II, Model LNQ22; Insertable Cardiac Monitor

Recall record Z-0421-2024 for Medtronic Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0421-2024
Company in FDA record
Medtronic Inc.
FDA classification date
Dec 1, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

It may create the potential for amplified noise and/or overall signal reduction of the ICM, which may interfere with intended recordings of heart rhythms. This noise pattern is different from occasional noise due to device position/migration, patient activity, or external electromagnetic interference.

Source facts

Action
Medtronic issued a MEDICAL DEVICE PERFORMANCE NOTIFICATION to its consignees on 11/03/2023 via UPS 2-day delivery. The notice explained the issue, potential hazards, and requested the following actions: Encourage enrollment in and regular transmissions to CareLink. - Medtronic will apply recurring algorithmic searches on CareLink for the noise pattern and notify the clinician if present. The information used to identify this pattern is not visible to the clinician through CareLink. No further action is required for patients regularly transmitting to CareLink. For patients not followed in CareLink: - Consider whether enrolling in CareLink is an option, per HRS/EHRA/APHRS/LAHRS guidance.1 Ongoing CareLink monitoring will reduce the potential for episodes caused by amplified noise to overwrite true episodes before they are reviewed. - If noise interferes with the ability to assess the patient s rhythm or reason for monitoring, contact Medtronic Technical Services for assistance (dxhelp@medtronic.com or 1-800-929-4043). On 06/19/2024, Medtronic sent an additional notice to consignees where they were notified of the additional units identified, encouraged enrollment in and regular transmissions to CareLink. For patients not followed with CareLink, consider enrolling. Hospitals were instructed to return unused units. Physicians were provided patient management recommendations. All consignees were requested to complete a confirmation form.
Initiated
2023-11-03
Root cause
Process change control
Distribution
US and Australia, Austria, Belgium, Brunei Darussalam, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Iceland, Ireland, Israel, Italy, Japan, Liechtenstein, Luxembourg, Macao, Malaysia, Netherlands, New Zealand, Northern Ireland, Norway, Portugal, Puerto Rico, Saudi Arabia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, United Arab Emirates, United Kingdom
Recall number
Z-0421-2024
Recall status
Open, Classified
CDRH record ID
204287
FDA classified
2023-12-01
Recall event number
93411

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗